De Burlo Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $855K | Hold |
6,133
| – | – | 0.19% | 58 |
|
|
2025
Q4 | $753K | Hold |
6,133
| – | – | 0.09% | 60 |
|
|
2025
Q3 | $681K | Buy |
6,133
+64
| +1% | +$7.28K | 0.08% | 61 |
|
|
2025
Q2 | $673K | Sell |
6,069
-996
| -14% | -$106K | 0.09% | 63 |
|
|
2025
Q1 | $792K | Hold |
7,065
| – | – | 0.12% | 58 |
|
|
2024
Q4 | $653K | Sell |
7,065
-750
| -10% | -$67.5K | 0.09% | 62 |
|
|
2024
Q3 | $655K | Sell |
7,815
-100
| -1% | -$7.63K | 0.08% | 65 |
|
|
2024
Q2 | $543K | Sell |
7,915
-683
| -8% | -$45.6K | 0.07% | 66 |
|
|
2024
Q1 | $630K | Sell |
8,598
-1,100
| -11% | -$84.6K | 0.08% | 67 |
|
|
2023
Q4 | $727K | Hold |
9,698
| – | – | 0.13% | 64 |
|
|
2023
Q3 | $727K | Sell |
9,698
-100
| -1% | -$7.69K | 0.13% | 64 |
|
|
2023
Q2 | $755K | Hold |
9,798
| – | – | 0.13% | 70 |
|
|
2023
Q1 | $813K | Hold |
9,798
| – | – | 0.16% | 71 |
|
|
2022
Q4 | $841K | Buy |
9,798
+600
| +7% | +$47.5K | 0.19% | 60 |
|
|
2022
Q3 | $567K | Buy |
+9,198
| New | +$580K | 0.14% | 65 |
|
|
2022
Q2 | – | Sell |
-9,381
| Closed | -$558K | – | 134 |
|
|
2022
Q1 | $558K | Sell |
9,381
-500
| -5% | -$32K | 0.1% | 69 |
|
|
2021
Q4 | $717K | Hold |
9,881
| – | – | 0.1% | 78 |
|
|
2021
Q3 | $690K | Sell |
9,881
-34
| -0.3% | -$2.39K | 0.11% | 76 |
|
|
2021
Q2 | $683K | Hold |
9,915
| – | – | 0.11% | 73 |
|
|
2021
Q1 | $641K | Hold |
9,915
| – | – | 0.11% | 73 |
|
|
2020
Q4 | $578K | Buy |
9,915
+800
| +9% | +$48.3K | 0.09% | 72 |
|
|
2020
Q3 | $576K | Sell |
9,115
-100
| -1% | -$6.93K | 0.1% | 67 |
|
|
2020
Q2 | $689K | Hold |
9,215
| – | – | 0.19% | 49 |
|
|
2020
Q1 | $689K | Sell |
9,215
-5,075
| -36% | -$351K | 0.19% | 49 |
|
|
2019
Q4 | $928K | Sell |
14,290
-1,000
| -7% | -$65.1K | 0.19% | 60 |
|
|
2019
Q3 | $969K | Sell |
15,290
-1,100
| -7% | -$71.9K | 0.22% | 56 |
|
|
2019
Q2 | $1.11M | Sell |
16,390
-900
| -5% | -$59.2K | 0.22% | 58 |
|
|
2019
Q1 | $1.12M | Sell |
17,290
-7,400
| -30% | -$492K | 0.23% | 66 |
|
|
2018
Q4 | $1.54M | Sell |
24,690
-685
| -3% | -$47.9K | 0.35% | 57 |
|
|
2018
Q3 | $1.96M | Sell |
25,375
-900
| -3% | -$68K | 0.37% | 71 |
|
|
2018
Q2 | $1.86M | Sell |
26,275
-900
| -3% | -$63.6K | 0.39% | 60 |
|
|
2018
Q1 | $2.05M | Sell |
27,175
-3,500
| -11% | -$278K | 0.45% | 53 |
|
|
2017
Q4 | $2.2M | Sell |
30,675
-800
| -3% | -$60.8K | 0.45% | 56 |
|
|
2017
Q3 | $2.55M | Sell |
31,475
-200
| -0.6% | -$15.3K | 0.57% | 51 |
|
|
2017
Q2 | $2.24M | Sell |
31,675
-500
| -2% | -$33.3K | 0.5% | 49 |
|
|
2017
Q1 | $2.19M | Sell |
32,175
-13,028
| -29% | -$916K | 0.47% | 54 |
|
|
2016
Q4 | $3.24M | Sell |
45,203
-3,372
| -7% | -$251K | 0.79% | 43 |
|
|
2016
Q3 | $3.84M | Sell |
48,575
-19,180
| -28% | -$1.56M | 1.07% | 41 |
|
|
2016
Q2 | $5.65M | Sell |
67,755
-22,358
| -25% | -$1.98M | 1.37% | 31 |
|
|
2016
Q1 | $8.28M | Sell |
90,113
-79,855
| -47% | -$7.2M | 2.39% | 13 |
|
|
2015
Q4 | $17.2M | Sell |
169,968
-13,450
| -7% | -$1.4M | 4.05% | 1 |
|
|
2015
Q3 | $18M | Buy |
183,418
+24,900
| +16% | +$2.77M | 4.23% | 1 |
|
|
2015
Q2 | $18.6M | Sell |
158,518
-700
| -0.4% | -$76.5K | 3.88% | 2 |
|
|
2015
Q1 | $15.6M | Sell |
159,218
-13,050
| -8% | -$1.33M | 3.09% | 2 |
|
|
2014
Q4 | $16.2M | Sell |
172,268
-14,000
| -8% | -$1.45M | 3.28% | 2 |
|
|
2014
Q3 | $19.8M | Sell |
186,268
-13,800
| -7% | -$1.35M | 4.38% | 2 |
|
|
2014
Q2 | $16.6M | Buy |
200,068
+25,550
| +15% | +$1.99M | 3.76% | 3 |
|
|
2014
Q1 | $12.4M | Buy |
174,518
+22,200
| +15% | +$1.74M | 2.98% | 6 |
|
|
2013
Q4 | $11.4M | Buy |
152,318
+1,700
| +1% | +$118K | 2.73% | 7 |
|
|
2013
Q3 | $9.47M | Sell |
150,618
-2,600
| -2% | -$155K | 2.58% | 9 |
|
|
2013
Q2 | $7.86M | Buy |
+153,218
| New | +$7.99M | 2.33% | 10 |
|
Other funds holding GILD
VCM
VPM
De Burlo Group's GILD Position: Q1 2026 in Review
De Burlo Group held its Gilead Sciences (GILD) position steady in Q1 2026 at 6,133 shares worth $855K. The position accounts for 0.19% of the portfolio, ranked #58.
De Burlo Group first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $19.8M in Q3 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- De Burlo Group held 6,133 shares of Gilead Sciences worth $855K as of Q1 2026.
- De Burlo Group left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.19% of De Burlo Group's portfolio in Q1 2026, its #58 holding.
- De Burlo Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- De Burlo Group's Gilead Sciences position peaked at $19.8M in Q3 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on De Burlo Group's 13F filing for Q1 2026, filed 14 May 2026.